4-hydroxy-butyric acid

4-hydroxy-butyric acid is a lipid of Fatty Acyls (FA) class.

Cross Reference

There are no associated biomedical information in the current reference collection.

Current reference collection contains 8613 references associated with 4-hydroxy-butyric acid in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.

Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.


Here are additional resources we collected from PubChem and MeSH for 4-hydroxy-butyric acid

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with 4-hydroxy-butyric acid

MeSH term MeSH ID Detail
Edema D004487 152 associated lipids
Encephalocele D004677 1 associated lipids
Epilepsy D004827 35 associated lipids
Epilepsies, Myoclonic D004831 2 associated lipids
Epilepsy, Absence D004832 5 associated lipids
Leukemia, Erythroblastic, Acute D004915 41 associated lipids
Exotropia D005099 1 associated lipids
Cardiac Complexes, Premature D005117 6 associated lipids
Failure to Thrive D005183 3 associated lipids
Femoral Fractures D005264 7 associated lipids
Per page 10 20 50 100 | Total 113

PubChem Associated disorders and diseases

PubChem Biomolecular Interactions and Pathways

NCBI Entrez Crosslinks

All references with 4-hydroxy-butyric acid

Download all related citations
Per page 10 20 50 100 | Total 3045
Authors Title Published Journal PubMed Link
Goodson SG et al. Metabolic substrates exhibit differential effects on functional parameters of mouse sperm capacitation. 2012 Biol. Reprod. pmid:22837480
Roll JM et al. Preference for gamma-hydroxybutyrate (GHB) in current users. 2012 J Exp Anal Behav pmid:22693361
Kornhauser A et al. Effects of cosmetic formulations containing hydroxyacids on sun-exposed skin: current applications and future developments. 2012 Dermatol Res Pract pmid:22675344
McElroy SL et al. Pharmacological management of binge eating disorder: current and emerging treatment options. 2012 Ther Clin Risk Manag pmid:22654518
van Amsterdam JG et al. [Cognitive impairment due to intensive use and overdoses of gammahydroxybutyric acid (GHB)]. 2012 Tijdschr Psychiatr pmid:23250641
Boyd JJ et al. Temporal differences in γ-hydroxybutyrate overdoses involving injecting drug users versus recreational drug users in Helsinki: a retrospective study. 2012 Scand J Trauma Resusc Emerg Med pmid:22296777
Spaeth M et al. Sodium oxybate therapy provides multidimensional improvement in fibromyalgia: results of an international phase 3 trial. 2012 Ann. Rheum. Dis. pmid:22294641
Lang C et al. Impaired chromatin remodelling at STAT1-regulated promoters leads to global unresponsiveness of Toxoplasma gondii-infected macrophages to IFN-γ. 2012 PLoS Pathog. pmid:22275866
Hensler JG et al. GABAB receptor-positive modulators: brain region-dependent effects. 2012 J. Pharmacol. Exp. Ther. pmid:21954301
Wanders RJ et al. Enzymology of the branched-chain amino acid oxidation disorders: the valine pathway. 2012 J. Inherit. Metab. Dis. pmid:21104317